The global CRO market value is expected to exceed $32 billion in 2017 and reach $45 billion by 2022, according to a report by Grand View Research, with growth attributed to greater R&D spend, M&A activity, as well as government contracts with CROs. The role of CROs in helping pharma and biopharma firms address today’s complex drug development challenges, has grown considerably these past few years.